COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs

  title={COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs},
  author={Godwell Nhamo and David Chikodzi and Hlengiwe Precious Kunene and Nthivhiseni Mashula},
  journal={Global Public Health},
  pages={319 - 339}
ABSTRACT The 2030 Agenda for Sustainable Development (AfSD) has the vision to leave no one behind, particularly low-income countries. Yet COVID-19 seems to have brought up new rules and approaches. Through document and critical discourse analysis, it emerges that there has been a surge in COVID-19 vaccines and treatments nationalism. Global solidarity is threatened, with the USA, United Kingdom, European Union and Japan having secured 1.3 billion doses of potential vaccines as of August 2020… 
Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing efficacy, hesitancy and SDG target 3.8
It is recommended that as the COVID-19 vaccines' regulatory authorisation continue in 2021, national vaccines and treatments regulatory bodies must be informed by science, with governments, civil society, politicians and other key stakeholders taking responsibility to educate the masses and continue taking the necessary precautions.
Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa
To halt this global pandemic, global responsibility must be accepted to finance and equitably distribute SARS-CoV-2 vaccines to African nations and COVAX must commit to vaccinating all of Africa and its initiative must be modified to account for the health and economic infrastructures in these countries.
Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning Approach
A metric to assess vaccination uptake and identify national socio-economic factors influencing this indicator is set up and Random Forest, an “off-the-shelf” machine learning algorithm, is used to study the association between vaccination uptake rate and socio- economic factors.
Critical prerequisites for Covid‐19 vaccine acceleration: A developing economy perspective
Analysis of data revealed that new structures, committees, advisory bodies and lines of communication in government evolved during this pandemic and are underlying the current strategy development and decision‐making on COVID‐19 vaccines.
COVID-19 Vaccines Development Discord: A Focus on the BRICS and Implications for Africa’s Access and Affordability Matters
ABSTRACT The 17th Sustainable Development Goal seeks to promote partnerships at various levels. To this end, COVID-19 vaccines development partnerships in the BRICS (Brazil, Russia, India, China and
COVID-19 Pandemic and Equal Access to Vaccines
This article analyzes, as regards the worldwide distribution of anti-COVID-19 vaccines, the various ways the principle of equity has been construed and applied or even overlooked.
Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis
The review revealed that barriers to COVID-19 health products were commonly caused by market forces, the unavailability, inaccessibility, and unaffordability of the products, incongruent donors' agenda and funding, and unreliable health and supply systems.
Global control of COVID-19: good vaccines may not suffice
How pandemic control in some countries and populations may face vaccine accessibility barriers if market forces strongly regulate the new technologies available, according to the inverse care law is discussed.
The Pandemic, Infodemic, and People’s Resilience in India: Viewpoint
The pivotal role of public participation and digital solutions to re-establish the authors' society is proposed and how Sustainable Development Goals (SDGs) can support eHealth initiatives and mitigate infodemics to tackle a postpandemic situation is described.


Access to COVID-19 Vaccines and Medicines - a Global Public Good
New daily record numbers of infections worldwide exacerbate concerns about the impact of the COVID-19 pandemic on regions of the Global South. Weak health systems, vulnerable economies, and extreme
The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
Here is a proposal for global cooperation to ensure equitable distribution of vaccines and therapies for COViD-19, with a common global interest.
COVID-19 vaccine development pipeline gears up
Minimum costs to manufacture new treatments for COVID-19
COVID-19 pandemic – an African perspective
The currently available literature on the epidemiology, etiology, vulnerability, preparedness and economic impact of COVID-19 in Africa, which could be useful and provide necessary information on ongoing CO VID-19 pandemics in the continent are collected and summarized.
COVID-19 vaccines
Professional organizations have recommended that these COVID-19 vaccines be offered to those who are breastfeeding because the potential benefits of maternal vaccination during lactation outweigh any theoretical risks.
Funding vaccines for emerging infectious diseases
The establishment of such a global vaccine fund is discussed, and some additional points to consider are provided for stimulating further discussion on this comprehensive, ambitious initiative.
COVID-19 and inequality: are we all in this together?
The key contributors to inequality are discussed, practical recommendations for public health decision-makers are made and the role of social inequalities as fuelling the spread of infections and the extent of their health impacts are highlighted.
Global Disparity and Solidarity in a Pandemic
Early methods to procure and develop treatments and vaccines by some high‐income countries reflect ongoing protectionist and nationalistic attitudes that can systemically exclude access for people in regions with weaker health systems.
Covid-19: trials of four potential treatments to generate “robust data” of what works
The World Health Organization (WHO) is to coordinate an international study of treatments for covid-19 that will focus on four potential treatment strategies, designed to put minimal burden on over-stretched hospitals.